GOP attorneys general warn CVS, Walgreens against mailing abortion pill in their states

GOP attorneys general warn CVS, Walgreens against mailing abortion pill in their states


Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.

Robyn Beck | AFP | Getty Images

Republican attorneys general in 20 states warned CVS and Walgreens this week against mailing abortion pills in their jurisdictions, indicating that they would take legal action.

“We emphasize that it is our responsibility as State Attorneys General to uphold the law and protect the health, safety, and well-being of women and unborn children in our states,” the attorneys general said in letters to the nation’s two largest drugstore chains Wednesday.

“Part of that responsibility includes ensuring that companies like yours are fully informed of the law so that harm does not come to our citizens,” the attorneys general warned.

The Food and Drug Administration approved mifepristone more than 20 years ago as a safe and effective way to terminate an early pregnancy. The FDA says scientific and real-world evidence demonstrate that the pill is safer than surgical abortion and childbirth.

The drugstores said last month that they are applying to become certified with the FDA to dispense the prescription pill in states where it is legal to do so.

CVS and Walgreens’ decision comes after the FDA recently changed its rules to allow retail pharmacies to dispense the pill for the first time as long as the prescription comes from a certified health-care provider.

CNBC has reached out to the companies for comment on the letters.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The pill, mifepristone, has become a central focus in the battle over abortion in the wake of the Supreme Court’s decision last June to overturn Roe v. Wade, which protected access to the procedure as constitutional right for 50 years.

A dozen states have basically banned abortion since the Supreme Court’s ruling. Other states have restrictions on mifepristone that conflict with FDA regulations on the medication.

The Biden administration last month issued a legal opinion arguing that the Postal Service can mail the pill to states where it is banned if the sender does not intend to break the law.

The Justice Department argued that even in states with severe restrictions on abortion, there are exceptions where mifepristone would be legal. The DOJ opinion came in response to a request from USPS, asking how it should navigate an 1873 law called the Comstock Act which prohibits sending anything used to terminate a pregnancy through the mail.

But the attorneys general dismissed the Justice Department opinion as “bizarre” and said they expect the courts to uphold their view that mifepristone cannot be sent by mail in their states.

There are several pending legal cases over the FDA’s approval of mifepristone. GenBioPro, one of the pill’s manufacturers, has sued to overturn West Virginia’s abortion ban, arguing that FDA approval of drugs pre-empts state law.

Anti-abortion physicians have sued the FDA in a federal court in Texas to completely pull mifepristone from the U.S. market. The FDA has called that lawsuit “extraordinary and unprecedented” and warned that a decision in the physicians favor would harm its approval powers.

The letters to CVS and Walgreens were signed by the attorneys general of Missouri, Alabama, Alaska, Arkansas, Florida, Georgia, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Montana, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Texas, Utah and West Virginia.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More